Access to medicines during the COVID-19 pandemic. The role of The Medicines Patent Pool

Greg Martin discusses the Medicines Patent Pool, a global health organization that improves access to essential medicines in low and middle-income countries. The Pool facilitates licensing agreements between patent holders and generic manufacturers, reducing drug prices and increasing availability. The model has proven successful, saving $1.6 billion and supplying 15 billion doses. The Medicines Patent Pool is also addressing COVID-19, ensuring affordable therapeutics reach underserved regions.

What is one of the main challenges faced by low and middle-income countries in accessing new medicines?

• Shortage of medical professionals

• Patent restrictions

• High transportation costs

• Lack of healthcare facilities

How does the Medicines Patent Pool help reduce the cost of medicines?

• By providing free medicines

• By subsidizing the cost of production

• By negotiating lower prices with patent holders

• By creating competition among multiple manufacturers

Which stakeholders does the Medicines Patent Pool collaborate with to ensure the uptake of medicines?

• Local pharmacies

• Private investors

• Pharmaceutical companies only

• Governments, international agencies, and civil society

What has been one of the significant achievements of the Medicines Patent Pool in the last decade?

• Providing free healthcare to all

• Eliminating all patent restrictions

• Saving $1.6 billion through its mechanism

• Developing new vaccines

Why is the role of the Medicines Patent Pool crucial in the context of the COVID-19 pandemic?

• It ensures that COVID-19 therapeutics are available only in wealthy countries

• It focuses on vaccine development

• It provides financial aid to healthcare workers

• It helps make COVID-19 therapeutics affordable and accessible in low and middle-income countries